Effect of Tissue Plasminogen Activator on Treatment Outcome and Neuronal Degeneration in Acute Ischemic Stroke
Background: Acute ischemic stroke [AIS] is a leading worldwide neurological morbidity with significant disability. Recombinant tissue plasminogen activator [r-TPA] is approved for the treatment of AIS.Neuron-specific enolase [NSE] is a marker of brain damage in patients with traumatic brain injury,...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Al-Azhar University, Faculty of Medicine (Damietta)
2021-01-01
|
| Colección: | International Journal of Medical Arts |
| Materias: | |
| Acceso en línea: | https://ijma.journals.ekb.eg/article_128608_ceb9da65899952b7db68f96c111b8614.pdf |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|